Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00420888
Status:
COMPLETED
Last Update Posted:
2015-07-22
First Post:
2007-01-09
Brief Title:
ABR-217620Naptumomab Estafenatox With Interferon-alpha IFN-alpha Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
Sponsor:
Active Biotech AB
Organization:
Active Biotech AB
Organization Data
Organization:
Active Biotech AB
Class:
INDUSTRY
Study ID:
06762004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Active Biotech AB
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None